Theile, D., & Czock, D. (2024). Perfusate flow rate: An overlooked factor in hyperthermic intraperitoneal chemotherapy (HIPEC)? Annals of surgical oncology, 31(13), . https://doi.org/10.1245/s10434-024-16060-8
Chicago Style (17th ed.) CitationTheile, Dirk, and David Czock. "Perfusate Flow Rate: An Overlooked Factor in Hyperthermic Intraperitoneal Chemotherapy (HIPEC)?" Annals of Surgical Oncology 31, no. 13 (2024). https://doi.org/10.1245/s10434-024-16060-8.
MLA (9th ed.) CitationTheile, Dirk, and David Czock. "Perfusate Flow Rate: An Overlooked Factor in Hyperthermic Intraperitoneal Chemotherapy (HIPEC)?" Annals of Surgical Oncology, vol. 31, no. 13, 2024, https://doi.org/10.1245/s10434-024-16060-8.
Warning: These citations may not always be 100% accurate.